US Patent 7396914 SARS nucleic acids, proteins, antibodies, and uses thereof
Patent 7396914 was granted and assigned to University of Massachusetts on July, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+96 characters)
Article
Patent abstract
Codon-optimized nucleic acids, polypeptides, and antibodies are described herein.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07396914 SARS nucleic acids, proteins, antibodies, and uses thereof US Patent 7396914 SARS nucleic acids, proteins, antibodies, and uses thereof
Infobox
Patent Number
0739691400
Patent Number
739691400
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073969140
Date of Patent
July 8, 2008
0Patent Application Number
109118380
Date Filed
August 4, 2004
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073969140
Date of Patent
July 8, 2008
0Patent Application Number
109118380
Date Filed
August 4, 2004
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07396914 SARS nucleic acids, proteins, antibodies, and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07396914
Date of patent
July 8, 2008
Patent application number
10911838
Date Filed
August 4, 2004
Patent primary examiner
Find more entities like US Patent 7396914 SARS nucleic acids, proteins, antibodies, and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
